The overall aim of this program of research is to improve the mental health of people who identify as LGBTQ+ by increasing their social support through a brief intervention. The purpose of the proposed project is to establish the effectiveness of our empirically-supported, brief acceptance-based behavioral therapy (ABBT). To achieve the specific aims, the investigators will conduct a fully-powered, randomized clinical trial (n=240) with two treatment arms: treatment-as-usual (TAU) vs. ABBT.
During the COVID-19 pandemic, up to 81% of adults in the United States experienced worsening mental health. A major cause was the social isolation triggered by the pandemic due to quarantining, loss of family or friends, and loss of work. For individuals who lost social connections or were unable to adapt to maintain their connections, social support decreased and loneliness worsened, putting them at much higher risk for anxiety and depressive symptoms. Importantly, people who identify as LGBTQ+ have been particularly affected by the social isolation caused by the pandemic and were already at much higher risk of social isolation, loneliness, and mental illness, including suicidality, before the pandemic. The objective of this R01 fully-powered trial is to examine the effectiveness of a brief acceptance-based behavioral telehealth intervention (ABBT) to improve mental health during the COVID-19 pandemic by strengthening social support among LGBTQ+ individuals. The aims of this proposal are: (1) to examine the effectiveness of ABBT in reducing mental health morbidity by conducting a fully-powered, RCT (n=240) of ABBT vs. Treatment-as-Usual; and, (2) to examine potential mediators and moderators of ABBT treatment effects. Primary outcomes will be anxiety and depressive symptoms.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
240
In the first session, the interventionist will introduce the concept of acceptance and its possible benefits in the context of life values and participant-identified challenges related to the COVID-19 pandemic, mental health, and social support. Interventionists will help participants identify potential challenges to acceptance. At the second session, participants will practice acceptance-based coping skills and a social support behavioral plan will be developed. These discussions will help the participant clarify how best to align their values with decisions on how to manage their mental health and social support in the context of the COVID-19 pandemic.
TAU includes brief mental health screening, consultation with providers, and referrals to psychotherapy and/or psychiatric medication.
Brown University
Providence, Rhode Island, United States
Hamilton Anxiety Rating Scale (HAM-A)
The interviewer-rated HAM-A is a measure of anxiety symptom severity.
Time frame: 39 weeks
Quick Inventory of Depressive Symptomatology - Clinician Rating (QIDS-C)
The interviewer-rated QIDS-C is a measure of depressive symptom severity.
Time frame: 39 weeks
Generalized Anxiety Disorder-7 (GAD-7)
The GAD-7 is a self-report measure of anxiety severity.
Time frame: 39 weeks
Patient Health Questionnaire-9 (PHQ-9)
The PHQ-9 is a self-report measure of depression severity.
Time frame: 39 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.